® Corporate Presentation December 1, 2020 The information in this slide deck is current as of December 1, 2020, unless otherwise noted, and is qualified in its entirety by reference to MacroGenics' Annual, Quarterly and Current Reports filed with the SEC. MacroGenics undertakes no obligation to update any of the information herein. Cautionary Note on Forward-Looking Statements 2 Legal Notices Any statements in these materials about future expectations, plans and prospects for MacroGenics ("Company"), includ ...

® Developing Breakthrough Biologics, Life-changing Medicines™ Corporate Presentation November 4, 2020 The information in this slide deck is current as of November 4, 2020, unless otherwise noted, and is qualified in its entirety by reference to MacroGenics' Annual, Quarterly and Current Reports filed with the SEC. MacroGenics undertakes no obligation to update any of the information herein. Cautionary Note on Forward-Looking Statements 2 Legal Notices Any statements in these materials about future expectati ...

MacroGenics, Inc. (NASDAQ:MGNX) Q3 2020 Earnings Conference Call November 4, 2020 4:30 PM ET Company Participants Anna Krassowska - Investor Relations Scott Koenig - President and CEO Jim Karrels - CFO Stephen Eck - CMO Conference Call Participants Yigal Nochomovitz - Citigroup Evan Seigerman - Credit Suisse Jonathan Miller - Evercore Stephen Willey - Stifel Etzer Darout - Guggenheim Securities Peter Lawson - Barclays Yigal Nochomovitz - Citigroup Operator Good afternoon. We will begin the MacroGenics 2020 ...

| --- | --- | --- | --- | --- | --- | |-------------------------------------------------------------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | ® | | | | | | | Developing Breakthrough Biologics, Life-changing Medicines™ | | | | | | | | | | | | | | Corporate Presentation September 14, 2020 | | | | | | The information in this slide deck is current as of September 14, 2020, unless otherwise noted, and is qualified in its entirety by reference to MacroGenics' Annual, Quarterly and Cu ...

MacroGenics, Inc. (NASDAQ:MGNX) Q2 2020 Earnings Conference Call July 30, 2020 4:30 PM ET Company Participants Anna Krassowska - Investor Relations Scott Koenig - President and CEO Jim Karrels - CFO Stephen Eck - CMO Conference Call Participants Debjit Chattopadhyay - H.C. Wainwright Paul Jeng - Guggenheim Securities Jonathan Miller - Evercore ISI Jonathan Chang - SVB Leerink Stephen Willey - Stifel Samantha Semenkow - Citi Peter Lawson - Barclays David Lebowitz - Morgan Stanley David Nierengarten - Wedbush ...

| --- | --- | --- | --- | --- | |-------------------------------------------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | ® | | | | | | | | | | | | Developing Breakthrough Biologics, Life-changing Medicines™ | | | | | | Corporate Presentation | | | | | | May 29, 2020 | | | | | The information in this slide deck is current as of May 29, 2020, unless otherwise noted, and is qualified in its entirety by reference to MacroGenics' Annual, Quarterly and Current Reports ...

| --- | --- | --- | --- | --- | --- | --- | |------------------------------------------|---------------------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Developing Breakthrough Biologics, Life- | changing Medicines™ | | | | | | | Corporate Presentation | | | | | | | | May 2020 | | | | | | | The information in this slide deck is current as of May 5, 2020, unless otherwise noted, and is qualified in its entirety by reference to Ma ...